Cardiology News & Physician Commentary. News, interviews & research from the top companies, universities, hospitals & physicians in cardiology. Profiles, interviews & research about the latest cardiology pharmaceuticals, technology & treatments. Profiles of the top companies, hospitals, universities, physicians & events in cardiology. Top Companies, Hospitals, Universities, Physicians & Events!
http://www.cardiologyeditorial.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.8 seconds
16x16
32x32
64x64
128x128
160x160
192x192
Terra Caudill
2425 N ●●●●●●●St #121
Hi●●ry , North Carolina, 28601
UNITED STATES
View this contact
Terra Caudill
2425 N ●●●●●●●St #121
Hi●●ry , North Carolina, 28601
UNITED STATES
View this contact
Terra Caudill
2425 N ●●●●●●●St #121
Hi●●ry , North Carolina, 28601
UNITED STATES
View this contact
BUY YOUR DOMAIN
11
YEARS
10
MONTHS
7
DAYS
GODADDY.COM, LLC
WHOIS : whois.godaddy.com
REFERRED : http://registrar.godaddy.com
PAGES IN
THIS WEBSITE
3
SSL
EXTERNAL LINKS
8
SITE IP
104.18.35.122
LOAD TIME
0.765 sec
SCORE
6.2
Cardiology Editorial | cardiologyeditorial.com Reviews
https://cardiologyeditorial.com
Cardiology News & Physician Commentary. News, interviews & research from the top companies, universities, hospitals & physicians in cardiology. Profiles, interviews & research about the latest cardiology pharmaceuticals, technology & treatments. Profiles of the top companies, hospitals, universities, physicians & events in cardiology. Top Companies, Hospitals, Universities, Physicians & Events!
cardiologyeditorial.com
Press Releases – Cardiology Editorial
http://cardiologyeditorial.com/category/press-releases
Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today. VYTORIN (ezetimibe/simvastatin) Significantly Reduced Cardiovascular Events More than Simvastatin Alone in Patients Presenting with Acute Coronary Syndromes in the Investigational IMPROVE-IT Study. North Wales first in Europe to connect cardiology departments with GE Healthcare’s Centricity Cardio Enterprise solution. GE Healthcare supporting a number of European hospit...
Events – Cardiology Editorial
http://cardiologyeditorial.com/category/events
Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today. VYTORIN (ezetimibe/simvastatin) Significantly Reduced Cardiovascular Events More than Simvastatin Alone in Patients Presenting with Acute Coronary Syndromes in the Investigational IMPROVE-IT Study. North Wales first in Europe to connect cardiology departments with GE Healthcare’s Centricity Cardio Enterprise solution. GE Healthcare supporting a number of European hospit...
Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today – Cardiology Editorial
http://cardiologyeditorial.com/2014/11/17/merck-announces-that-improve-it-achieved-primary-endpoint-data-to-be-presented-at-american-heart-association-scientific-sessions-today
Merck Announces that IMPROVE-IT Achieved Primary Endpoint; Data to be Presented at American Heart Association Scientific Sessions Today. Data are Embargoed by American Heart Association until 10:45 AM CT Today. Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck’s 2...
TOTAL PAGES IN THIS WEBSITE
3
NICE Issues Final Positive Recommendation for National Commissioning of Soliris® (eculizumab) for All Patients with aHUS in England – Physician Editorial
http://physicianeditorial.com/2014/11/27/nice-issues-final-positive-recommendation-for-national-commissioning-of-soliris-eculizumab-for-all-patients-with-ahus-in-england
Medical Knowledge by the Experts. NICE Issues Final Positive Recommendation for National Commissioning of Soliris (eculizumab) for All Patients with aHUS in England. Final Evaluation Determination Confirms that Soliris is a Very Effective Treatment for aHUS with Significant Value to Patients. Final Evaluation Determination Includes the Same Conditions Discussed in Draft Recommendation, Including Establishment of an Expert Center and a Robust System to Monitor Patients Receiving Treatment. As noted by NIC...
Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive Disorder – Physician Editorial
http://physicianeditorial.com/2015/01/06/alkermes-announces-positive-results-from-study-of-alks-5461-for-treatment-of-major-depressive-disorder
Medical Knowledge by the Experts. Alkermes Announces Positive Results From Study of ALKS 5461 for Treatment of Major Depressive Disorder. Safety and Tolerability Profile of ALKS 5461 Confirmed in FORWARD-1 Study, a Supportive Study in the FORWARD Phase 3 Pivotal Program. Dosing Regimen Confirmed; Efficacy Data Showed Statistically Significant Improvements in Depression Scores Beginning at Week One and Continuing Through Eight-Week Treatment Period. About the Phase 3 FORWARD Clinical Program. ALKS 5461 is...
Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia – Physician Editorial
http://physicianeditorial.com/2015/01/07/alkermes-announces-positive-results-of-phase-2-clinical-trial-of-alks-3831-in-schizophrenia
Medical Knowledge by the Experts. Alkermes Announces Positive Results of Phase 2 Clinical Trial of ALKS 3831 in Schizophrenia. Once-Daily, Oral Product Candidate Showed Efficacy Equivalent to Olanzapine With Clinically Meaningful and Statistically Significant Lower Weight Gain in 300-Patient Study. Company Plans to Initiate Pivotal Development Program in 2015. Weight gain observed in the olanzapine-only arm was consistent with that reported in the olanzapine label. Additional analyses focused on those pa...
New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris® (eculizumab) Treatment – Physician Editorial
http://physicianeditorial.com/2014/12/08/new-data-presented-at-ash-annual-meeting-enhance-clinical-knowledge-of-ahus-and-pnh-and-underscore-the-effectiveness-of-soliris-eculizumab-treatment
Medical Knowledge by the Experts. New Data Presented at ASH Annual Meeting Enhance Clinical Knowledge of aHUS and PNH and Underscore the Effectiveness of Soliris (eculizumab) Treatment. New Analyses Report Clinical Benefits of Ongoing Soliris Therapy in Children and Adults with aHUS With or Without Identified Genetic Mutations. Observational Data Highlight Importance of High Sensitivity Flow Cytometry to Enable Reliable Detection of PNH Cells. Eculizumab is an Effective Treatment for Atypical Hemolytic U...
Sequenta Launches New Online Results Portal for Physicians – Physician Editorial
http://physicianeditorial.com/2014/12/04/sequenta-launches-new-online-results-portal-for-physicians
Medical Knowledge by the Experts. Sequenta Launches New Online Results Portal for Physicians. Secure, real-time access to ClonoSIGHT test results, order status, patient MRD trends. A fully functional demo of the ClonoSIGHT Secure Portal available at https:/ demo.clonosight.com, allows physicians to explore each feature of the portal. Physicians can also demo the portal at the 56th Annual Meeting of the American Society Hematology (Booth #1243). The portal was developed in collaboration wi...Sequenta’s Cl...
Press Releases – Physician Editorial
http://physicianeditorial.com/category/press-releases
Medical Knowledge by the Experts. Pfizer Announces the Publication of Final Results from Two Pivotal Phase 3 Studies of Crisaborole Topical Ointment in Patients with Mild to Moderate Atopic Dermatitis. Pfizer Receives FDA Approval for Prevnar 13 in Adults Age 18 Through 49. Pfizer Announces Positive Top-Line Results From Phase 3 S-TRAC Trial of SUTENT (sunitinib) as Adjuvant Therapy in Patients at High Risk of Recurrent Renal Cell Carcinoma. S-TRAC is the First RCC Trial of a Tyrosine Kinase Inhibitor to...
Hospitals – Physician Editorial
http://physicianeditorial.com/hospitals
Medical Knowledge by the Experts. Newfoundland and Labrador Establishing Provincial Telepathology Network. West Kendall Baptist Hospital First in the World to Scan Patients with GE’s New Revolution CT System. Elekta announces strategic partnership with McLaren Health Care to improve cancer care in Michigan. Agreement secures full Elekta solution across the McLaren enterprise STOCKHOLM, December 18, 2013 The ability to effectively manage data across disparate health systems to help drive quality care will...
TOTAL LINKS TO THIS WEBSITE
8
cardiologydomain.com
The Sponsored Listings displayed above are served automatically by a third party. Neither the service provider nor the domain owner maintain any relationship with the advertisers. In case of trademark issues please contact the domain owner directly (contact information can be found in whois).
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
Dunedin Cardiologist Accepting New Patients.Dunedin Cardiologist
Welcome to the website of Dr. Patrice Moreno a Cardiologist located in Dunedin, FL. If this is an emergency call 911. About Dr. Moreno. WE ARE ACCEPTING ACCEPTING NEW PATIENTS! DR MORENO ACCEPTS MOST MAJOR INSURANCES. PLEASE CALL TO SCHEDULE YOUR APPOINTMENT TODAY. Dr Patrice Moreno – Cardiologist Dunedin, FL. Welcome to Dr. Patrice A. Moreno a Cardiologist. In Dunedin, FL. Located in Dunedin, FL. Practice includes all aspects of Cardiology. Monday – 8am – 2pm. Tuesday – 8am – 2pm.
cardiology ebooks
11 Mayıs 2009 Pazartesi. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Publisher: Saunders; 8 edition (October 16, 2007). Product Dimensions: 11.2 x 8.8 x 2.6 inches. Http:/ www.medishared.net/mediforum/braunwalds-heart-disease-textbook-cardiovascular-medicine-8th-edition-t14058.html. Braunwalds Heart Disease: A Textbook of Cardiovas.
Pfizer e-Congress
Skip directly to content. Bulling, una nueva epidemia. Read more about DSM 5: Qué esperar de nuevo? Read more about Homepage. Usted se dirige a: www.cardiologyecongressla.com. En su región se requiere por ley validar su estatus como profesional de la salud. Únicamente para profesionales de la salud. Por favor seleccione su país:. Confirmo que soy profesional de la salud residente en el país seleccionado anteriormente. Você está acessando: www.cardiologyecongressla.com. Apenas para profissionais de saúde.
Cardiology Editorial
Cardiology News & Physician Commentary. News, interviews & research from the top companies, universities, hospitals & physicians in cardiology. Profiles, interviews & research about the latest cardiology pharmaceuticals, technology & treatments. Profiles of the top companies, hospitals, universities, physicians & events in cardiology. Top Companies, Hospitals, Universities, Physicians & Events!
cardiologyelectronic.com
Welcome to: cardiologyelectronic.com. This Web page is parked for FREE, courtesy of GoDaddy.com. Is this your domain? Let's turn it into a website! Would you like to buy this. THE domain at THE price. Visit GoDaddy.com for the best values on. Restrictions apply. See website for details.
Cardiology Elite
The Future of Cardiology is Elite. A website created by GoDaddy’s Website Builder.
Cardiology EMR Software | 1st Providers Choice
Call Us Today 480-782-1116. Cardiology EMR and PM Solution. Highly customizable software designed for Cardiology providers. Designed with direct input from practicing cardiologists, our EMR is the ideal charting solution for cardiology specialists. The software is fully certified and HIPAA-compliant and meets industry standards for security and Meaningful Use. EMR on the iPad. EMR on Mobile Devices. 2018 1st Providers Choice.
Price Request - BuyDomains
Url=' escape(document.location.href) , 'Chat367233609785093432', 'toolbar=0,scrollbars=0,location=0,statusbar=0,menubar=0,resizable=0,width=640,height=500');return false;". Need a price instantly? Just give us a call. Toll Free in the U.S. We can give you the price over the phone, help you with the purchase process, and answer any questions. Get a price in less than 24 hours. Fill out the form below. One of our domain experts will have a price to you within 24 business hours. United States of America.
